Systemic inflammatory response and neuromuscular involvement in amyotrophic lateral sclerosis

Abstract

Neuromuscular pathology in ALS involves the systemic regulation of inflammatory markers mostly active on T-cell immune responses. Disease stratification based on the prognostic value of circulating inflammatory markers could improve clinical trials design in ALS.